Findings indicate that anti-SP100 antibody has an important diagnostic role in AMA-negative PBC patients, while anti-gp210 has the best predictive value regarding progression to end-stage hepatic failure (7, 13). The gene discussed is NUP210; the disease is primary biliary cholangitis.